Lee F, Nguyen U, Munns E, Wachs R
PLoS One. 2024; 19(5):e0300254.
PMID: 38696450
PMC: 11065314.
DOI: 10.1371/journal.pone.0300254.
Li T, Trinh T, Bosco A, Kiernan M, Goldstein D, Park S
Support Care Cancer. 2024; 32(5):278.
PMID: 38592525
PMC: 11003903.
DOI: 10.1007/s00520-024-08484-5.
Park S, Cetinkaya-Fisgin A, Argyriou A, Hoke A, Cavaletti G, Alberti P
J Neurol Neurosurg Psychiatry. 2023; 94(11):962-972.
PMID: 37015772
PMC: 10579520.
DOI: 10.1136/jnnp-2021-328323.
Geisler S
Exp Neurol. 2020; 336:113519.
PMID: 33129841
PMC: 11160556.
DOI: 10.1016/j.expneurol.2020.113519.
McLeod J
J R Coll Physicians Lond. 2019; 5(3):255-262.
PMID: 30667676
PMC: 5366616.
Editor's Highlight: Multiparametric Image Analysis of Rat Dorsal Root Ganglion Cultures to Evaluate Peripheral Neuropathy-Inducing Chemotherapeutics.
Guo L, Hamre 3rd J, Eldridge S, Behrsing H, Cutuli F, Mussio J
Toxicol Sci. 2017; 156(1):275-288.
PMID: 28115644
PMC: 5837782.
DOI: 10.1093/toxsci/kfw254.
Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice.
Boehmerle W, Huehnchen P, Peruzzaro S, Balkaya M, Endres M
Sci Rep. 2014; 4:6370.
PMID: 25231679
PMC: 5377307.
DOI: 10.1038/srep06370.
An overlooked complication of vancomycin induced acute flaccid paralysis in a child with acute leukemia: a case report.
Al Alawi K, Al Shinawy M, Taqee A, Wali Y
Oman Med J. 2011; 26(4):283-4.
PMID: 22043437
PMC: 3191713.
DOI: 10.5001/omj.2011.69.
Microtubule-disrupting chemotherapeutics result in enhanced proteasome-mediated degradation and disappearance of tubulin in neural cells.
Huff L, Sackett D, Poruchynsky M, Fojo T
Cancer Res. 2010; 70(14):5870-9.
PMID: 20587529
PMC: 2908375.
DOI: 10.1158/0008-5472.CAN-09-4281.
Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration.
Ravula S, Wang M, McClain M, Asress S, Frazier B, Glass J
Neurosci Lett. 2007; 415(1):34-9.
PMID: 17267126
PMC: 2665290.
DOI: 10.1016/j.neulet.2007.01.009.
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Verstappen C, Heimans J, Hoekman K, Postma T
Drugs. 2003; 63(15):1549-63.
PMID: 12887262
DOI: 10.2165/00003495-200363150-00003.
Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat.
Tanner K, Reichling D, Levine J
J Neurosci. 1998; 18(16):6480-91.
PMID: 9698336
PMC: 6793188.
Long-term effects of vincristine on the peripheral nervous system.
Postma T, Benard B, Huijgens P, Ossenkoppele G, Heimans J
J Neurooncol. 1993; 15(1):23-7.
PMID: 8384253
DOI: 10.1007/BF01050259.
Effects of lymphoma on the peripheral nervous system.
Hughes R, Britton T, Richards M
J R Soc Med. 1994; 87(9):526-30.
PMID: 7932460
PMC: 1294770.
DOI: 10.1177/014107689408700915.
Retardation of rat sciatic nerve regeneration after local application of minute doses of vincristine.
Ruigt G, den Brok M
Cancer Chemother Pharmacol. 1995; 36(6):530-5.
PMID: 7554046
DOI: 10.1007/BF00685804.
Neurotoxicology of vincristine in the cat. Electrophysiological studies.
Goldstein B, Lowndes H, Cho E
Arch Toxicol. 1981; 48(4):253-64.
PMID: 7316760
DOI: 10.1007/BF00319653.
Neurotoxicology of vincristine in the cat. Morphological study.
Cho E, Lowndes H, Goldstein B
Arch Toxicol. 1983; 52(2):83-90.
PMID: 6303274
DOI: 10.1007/BF00354768.
Vincristine neurotoxicity. Pathophysiology and management.
Legha S
Med Toxicol. 1986; 1(6):421-7.
PMID: 3540519
DOI: 10.1007/BF03259853.
Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nerves.
Di Gregorio F, Favaro G, Panozzo C, Fiori M
Cancer Chemother Pharmacol. 1990; 26(1):31-6.
PMID: 2322988
DOI: 10.1007/BF02940290.
Exogenously administered gangliosides fail to increase in vivo metastatic frequency or in vitro growth of murine neoplastic cells.
Facci L, Skaper S, Presti D, Kirschner G, Leon A, Chieco-Bianchi L
Clin Exp Metastasis. 1990; 8(2):181-92.
PMID: 2317958
DOI: 10.1007/BF00117791.
